MEDIAN Technologies SA engages in the development and market of software publishing solutions and provision of services in the field of medical imaging in oncology. It operates through the Drug Development and Patient Care segments. It offers services and exploitation of medical images for the diagnosis and follow-up of cancer patients. The firm operates the iBiopsy platform. The company was founded by Fredrik Bjjorn Brag, Gérard Milhiet and Arnaud Butzbach in 2002 and is headquartered in Valbonne, France.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company